| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Zebrafish | 3 | 2018 | 181 | 0.90 | Why? |
| Drosophila melanogaster | 2 | 2018 | 85 | 0.90 | Why? |
| Growth and Development | 1 | 2018 | 4 | 0.79 | Why? |
| Snail Family Transcription Factors | 1 | 2018 | 20 | 0.78 | Why? |
| Motion | 1 | 2018 | 63 | 0.76 | Why? |
| Receptors, Notch | 1 | 2018 | 59 | 0.75 | Why? |
| Sulfonylurea Compounds | 1 | 2018 | 79 | 0.72 | Why? |
| Caenorhabditis elegans | 1 | 2018 | 82 | 0.71 | Why? |
| Adaptation, Biological | 1 | 2018 | 179 | 0.69 | Why? |
| S100 Calcium Binding Protein beta Subunit | 1 | 2017 | 63 | 0.67 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2018 | 192 | 0.64 | Why? |
| Genome | 2 | 2018 | 341 | 0.64 | Why? |
| Social Media | 3 | 2021 | 5798 | 0.58 | Why? |
| Diabetic Nephropathies | 1 | 2018 | 315 | 0.57 | Why? |
| Selection, Genetic | 1 | 2018 | 691 | 0.56 | Why? |
| Biological Evolution | 2 | 2018 | 641 | 0.52 | Why? |
| Pseudomonas Infections | 1 | 2018 | 425 | 0.52 | Why? |
| B7-H1 Antigen | 1 | 2017 | 541 | 0.51 | Why? |
| Anemia | 1 | 2020 | 789 | 0.51 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.51 | Why? |
| Glioblastoma | 3 | 2017 | 187 | 0.42 | Why? |
| Hematology | 1 | 2017 | 649 | 0.42 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2018 | 861 | 0.41 | Why? |
| Gene Duplication | 2 | 2018 | 31 | 0.38 | Why? |
| Pancreatitis | 1 | 2017 | 688 | 0.37 | Why? |
| Mice | 8 | 2019 | 21357 | 0.36 | Why? |
| Natural Killer T-Cells | 2 | 2018 | 191 | 0.31 | Why? |
| Evolution, Molecular | 3 | 2018 | 3691 | 0.31 | Why? |
| Brain Neoplasms | 3 | 2017 | 669 | 0.31 | Why? |
| Community-Acquired Infections | 1 | 2018 | 2328 | 0.31 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.30 | Why? |
| Monocytes | 2 | 2020 | 2978 | 0.30 | Why? |
| Parkinson Disease | 1 | 2017 | 1414 | 0.28 | Why? |
| Blood-Brain Barrier | 2 | 2019 | 531 | 0.27 | Why? |
| Immunotherapy, Adoptive | 2 | 2018 | 524 | 0.25 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.24 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.24 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.24 | Why? |
| Klebsiella pneumoniae | 2 | 2018 | 658 | 0.24 | Why? |
| Algorithms | 2 | 2018 | 7346 | 0.23 | Why? |
| Transcriptome | 4 | 2020 | 3466 | 0.23 | Why? |
| Attitude | 2 | 2021 | 1481 | 0.23 | Why? |
| Soybeans | 2 | 2018 | 50 | 0.22 | Why? |
| Travel | 1 | 2020 | 7220 | 0.22 | Why? |
| Brain | 2 | 2017 | 5133 | 0.21 | Why? |
| Streptolysins | 1 | 2019 | 8 | 0.20 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.20 | Why? |
| Glycyrrhizic Acid | 1 | 2022 | 190 | 0.20 | Why? |
| Meningitis, Pneumococcal | 1 | 2019 | 35 | 0.19 | Why? |
| Gene Transfer, Horizontal | 1 | 2018 | 64 | 0.19 | Why? |
| Myeloblastin | 1 | 2018 | 57 | 0.18 | Why? |
| Jumonji Domain-Containing Histone Demethylases | 1 | 2018 | 28 | 0.18 | Why? |
| Neonicotinoids | 1 | 2018 | 14 | 0.18 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.18 | Why? |
| South America | 1 | 2020 | 565 | 0.18 | Why? |
| HLA-DR Serological Subtypes | 1 | 2017 | 2 | 0.18 | Why? |
| Isoflavones | 1 | 2018 | 52 | 0.18 | Why? |
| Bumetanide | 1 | 2017 | 2 | 0.18 | Why? |
| Solute Carrier Family 12, Member 2 | 1 | 2017 | 2 | 0.18 | Why? |
| Bees | 1 | 2018 | 41 | 0.18 | Why? |
| Galactosylceramides | 1 | 2017 | 22 | 0.18 | Why? |
| Homovanillic Acid | 1 | 2017 | 4 | 0.18 | Why? |
| Thymus Gland | 1 | 2018 | 126 | 0.18 | Why? |
| Polyesters | 1 | 2018 | 94 | 0.18 | Why? |
| Flatfishes | 1 | 2017 | 1 | 0.18 | Why? |
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2017 | 9 | 0.18 | Why? |
| Tyrosine 3-Monooxygenase | 1 | 2017 | 32 | 0.18 | Why? |
| Gene Expression Regulation, Developmental | 1 | 2018 | 159 | 0.18 | Why? |
| Receptors, Dopamine D2 | 1 | 2017 | 22 | 0.17 | Why? |
| Salinity | 1 | 2017 | 11 | 0.17 | Why? |
| Radiation-Sensitizing Agents | 1 | 2017 | 16 | 0.17 | Why? |
| Vocabulary, Controlled | 1 | 2017 | 26 | 0.17 | Why? |
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2017 | 49 | 0.17 | Why? |
| beta-Lactam Resistance | 1 | 2018 | 150 | 0.17 | Why? |
| Dacarbazine | 1 | 2017 | 67 | 0.17 | Why? |
| Endothelial Progenitor Cells | 1 | 2018 | 103 | 0.17 | Why? |
| Phantoms, Imaging | 1 | 2017 | 146 | 0.17 | Why? |
| Semantics | 1 | 2017 | 104 | 0.17 | Why? |
| Indazoles | 1 | 2017 | 77 | 0.16 | Why? |
| Wireless Technology | 1 | 2018 | 180 | 0.16 | Why? |
| Levodopa | 1 | 2017 | 87 | 0.16 | Why? |
| Longevity | 1 | 2018 | 159 | 0.16 | Why? |
| Dopamine | 1 | 2017 | 123 | 0.16 | Why? |
| Oxidative Stress | 2 | 2018 | 2050 | 0.16 | Why? |
| Cephalosporins | 1 | 2018 | 250 | 0.16 | Why? |
| Animals | 16 | 2019 | 78931 | 0.16 | Why? |
| Support Vector Machine | 1 | 2018 | 330 | 0.16 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.16 | Why? |
| Insecticides | 1 | 2018 | 178 | 0.16 | Why? |
| Klebsiella Infections | 2 | 2018 | 466 | 0.15 | Why? |
| Language | 1 | 2021 | 655 | 0.15 | Why? |
| Prodrugs | 1 | 2018 | 264 | 0.15 | Why? |
| Ascorbic Acid | 1 | 2022 | 676 | 0.15 | Why? |
| Plant Proteins | 1 | 2017 | 194 | 0.15 | Why? |
| North America | 1 | 2020 | 1400 | 0.15 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.15 | Why? |
| Plasmids | 1 | 2018 | 840 | 0.15 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2017 | 242 | 0.15 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 1014 | 0.14 | Why? |
| APACHE | 1 | 2017 | 682 | 0.14 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 317 | 0.14 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.14 | Why? |
| Genome, Bacterial | 1 | 2018 | 446 | 0.13 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.13 | Why? |
| Streptococcus pneumoniae | 1 | 2019 | 827 | 0.13 | Why? |
| Mice, Inbred C57BL | 3 | 2018 | 5542 | 0.13 | Why? |
| Asia | 1 | 2020 | 2399 | 0.12 | Why? |
| Respiratory Therapy | 1 | 2020 | 918 | 0.12 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.12 | Why? |
| Interleukin-1beta | 1 | 2018 | 992 | 0.12 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.12 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.12 | Why? |
| Drugs, Chinese Herbal | 2 | 2018 | 2760 | 0.12 | Why? |
| Metabolome | 1 | 2017 | 624 | 0.12 | Why? |
| beta-Lactamases | 1 | 2018 | 759 | 0.12 | Why? |
| Drug Carriers | 1 | 2018 | 590 | 0.12 | Why? |
| Intention | 1 | 2021 | 1380 | 0.12 | Why? |
| Mass Spectrometry | 1 | 2018 | 1165 | 0.12 | Why? |
| Brain Injuries, Traumatic | 1 | 2017 | 381 | 0.12 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.11 | Why? |
| Membrane Proteins | 2 | 2019 | 1733 | 0.11 | Why? |
| Antineoplastic Agents | 2 | 2018 | 3550 | 0.11 | Why? |
| Paracoccidioides | 1 | 2010 | 12 | 0.11 | Why? |
| Neurons | 1 | 2017 | 864 | 0.11 | Why? |
| Phytosterols | 1 | 2010 | 22 | 0.11 | Why? |
| Up-Regulation | 1 | 2019 | 2249 | 0.11 | Why? |
| Sepsis | 2 | 2018 | 3517 | 0.11 | Why? |
| Humans | 29 | 2022 | 930598 | 0.11 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.10 | Why? |
| China | 8 | 2021 | 50654 | 0.10 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.10 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.10 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.10 | Why? |
| Cough | 2 | 2020 | 4891 | 0.10 | Why? |
| Cell Line, Tumor | 4 | 2020 | 3608 | 0.10 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.09 | Why? |
| Dendritic Cells | 1 | 2017 | 1330 | 0.09 | Why? |
| Phosphoproteins | 1 | 2019 | 4346 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| Sulfonamides | 1 | 2017 | 1294 | 0.09 | Why? |
| Life Style | 1 | 2020 | 2708 | 0.09 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.08 | Why? |
| Disease Models, Animal | 4 | 2018 | 10998 | 0.08 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.08 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
| Health Status | 1 | 2020 | 3259 | 0.08 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Fever | 2 | 2020 | 7795 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| Nanoparticles | 1 | 2018 | 2040 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.08 | Why? |
| Otolaryngology | 1 | 2020 | 1917 | 0.08 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.07 | Why? |
| Choledocholithiasis | 1 | 2005 | 33 | 0.07 | Why? |
| Reproducibility of Results | 3 | 2017 | 11304 | 0.07 | Why? |
| Arthritis, Rheumatoid | 1 | 2018 | 2043 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Neoplasm Invasiveness | 2 | 2017 | 582 | 0.07 | Why? |
| Rats, Sprague-Dawley | 2 | 2018 | 987 | 0.07 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.07 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.07 | Why? |
| Aged | 9 | 2021 | 215776 | 0.07 | Why? |
| Methyltransferases | 1 | 2010 | 720 | 0.07 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.07 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.07 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.07 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.07 | Why? |
| Phylogeny | 3 | 2018 | 13341 | 0.07 | Why? |
| Internationality | 1 | 2017 | 3297 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.07 | Why? |
| Female | 13 | 2021 | 380317 | 0.07 | Why? |
| Electronic Health Records | 1 | 2017 | 3492 | 0.06 | Why? |
| Cholecystectomy, Laparoscopic | 1 | 2005 | 120 | 0.06 | Why? |
| Retrospective Studies | 5 | 2022 | 105322 | 0.06 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.06 | Why? |
| Male | 15 | 2021 | 367725 | 0.06 | Why? |
| Cell Movement | 2 | 2017 | 695 | 0.06 | Why? |
| Europe | 1 | 2020 | 12702 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.06 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.06 | Why? |
| Adult | 9 | 2021 | 244371 | 0.06 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.06 | Why? |
| Acute Kidney Injury | 1 | 2021 | 5762 | 0.06 | Why? |
| Kinetin | 1 | 2020 | 11 | 0.06 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.06 | Why? |
| Virulence | 2 | 2018 | 2172 | 0.05 | Why? |
| Chromatography, High Pressure Liquid | 2 | 2018 | 669 | 0.05 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.05 | Why? |
| Rats | 2 | 2018 | 2764 | 0.05 | Why? |
| Ribonucleosides | 1 | 2020 | 95 | 0.05 | Why? |
| Lepidoptera | 1 | 2018 | 26 | 0.05 | Why? |
| Animal Structures | 1 | 2018 | 61 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Food-Drug Interactions | 1 | 2018 | 24 | 0.05 | Why? |
| Rats, Inbred SHR | 1 | 2018 | 58 | 0.05 | Why? |
| Cell Line | 3 | 2020 | 12040 | 0.05 | Why? |
| Neoplasm Transplantation | 1 | 2018 | 55 | 0.05 | Why? |
| Culture Media, Conditioned | 1 | 2018 | 66 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Genes, Duplicate | 1 | 2017 | 1 | 0.05 | Why? |
| Genomic Islands | 1 | 2018 | 26 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.05 | Why? |
| Beekeeping | 1 | 2018 | 13 | 0.05 | Why? |
| Liquid-Liquid Extraction | 1 | 2018 | 60 | 0.05 | Why? |
| Lethal Dose 50 | 1 | 2018 | 63 | 0.05 | Why? |
| Bacterial Load | 1 | 2018 | 179 | 0.05 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.05 | Why? |
| Interspersed Repetitive Sequences | 1 | 2018 | 29 | 0.05 | Why? |
| Permeability | 1 | 2019 | 238 | 0.04 | Why? |
| Robotics | 1 | 2005 | 528 | 0.04 | Why? |
| Heterografts | 1 | 2018 | 203 | 0.04 | Why? |
| Discriminant Analysis | 1 | 2018 | 170 | 0.04 | Why? |
| Universal Precautions | 1 | 2020 | 293 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Systematized Nomenclature of Medicine | 1 | 2017 | 30 | 0.04 | Why? |
| Gonads | 1 | 2017 | 17 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 28 | 0.04 | Why? |
| Least-Squares Analysis | 1 | 2018 | 254 | 0.04 | Why? |
| Neovascularization, Physiologic | 1 | 2018 | 160 | 0.04 | Why? |
| Exons | 1 | 2017 | 158 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| Antineoplastic Agents, Alkylating | 1 | 2017 | 71 | 0.04 | Why? |
| Biomarkers, Pharmacological | 1 | 2018 | 150 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Vertebrates | 1 | 2017 | 127 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Adenosine | 1 | 2020 | 509 | 0.04 | Why? |
| In Situ Hybridization | 1 | 2017 | 390 | 0.04 | Why? |
| Random Allocation | 1 | 2018 | 773 | 0.04 | Why? |
| Cell Cycle | 1 | 2017 | 329 | 0.04 | Why? |
| Rats, Wistar | 1 | 2017 | 621 | 0.04 | Why? |
| Principal Component Analysis | 1 | 2018 | 689 | 0.04 | Why? |
| Cerebral Infarction | 1 | 2018 | 245 | 0.04 | Why? |
| Serogroup | 1 | 2018 | 510 | 0.04 | Why? |
| Nervous System | 1 | 2017 | 303 | 0.04 | Why? |
| Brain Edema | 1 | 2017 | 224 | 0.04 | Why? |
| Virulence Factors | 1 | 2018 | 338 | 0.04 | Why? |
| Otolaryngologists | 1 | 2020 | 533 | 0.04 | Why? |
| Chromatography, Liquid | 1 | 2018 | 640 | 0.04 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.04 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.04 | Why? |
| Spleen | 1 | 2018 | 877 | 0.03 | Why? |
| Breast | 1 | 2017 | 290 | 0.03 | Why? |
| Quality Control | 1 | 2018 | 628 | 0.03 | Why? |
| Regression Analysis | 1 | 2021 | 2484 | 0.03 | Why? |
| United States | 1 | 2021 | 46150 | 0.03 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.03 | Why? |
| Lipopolysaccharides | 1 | 2018 | 848 | 0.03 | Why? |
| Gold | 1 | 2017 | 592 | 0.03 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.03 | Why? |
| Tandem Mass Spectrometry | 1 | 2018 | 1031 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.03 | Why? |
| Cholestadienols | 1 | 2010 | 2 | 0.03 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.03 | Why? |
| Alkylation | 1 | 2010 | 5 | 0.03 | Why? |
| Lanosterol | 1 | 2010 | 6 | 0.03 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.03 | Why? |
| Exosomes | 1 | 2017 | 567 | 0.03 | Why? |
| Cell Survival | 1 | 2017 | 1581 | 0.03 | Why? |
| Chromatography, Gas | 1 | 2010 | 25 | 0.03 | Why? |
| Patient Readmission | 1 | 2020 | 1543 | 0.03 | Why? |
| Tyrosine | 1 | 2010 | 66 | 0.03 | Why? |
| Biocatalysis | 1 | 2010 | 100 | 0.03 | Why? |
| Metal Nanoparticles | 1 | 2017 | 771 | 0.03 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 238 | 0.03 | Why? |
| Limit of Detection | 1 | 2018 | 2698 | 0.03 | Why? |
| RNA-Binding Proteins | 1 | 2017 | 1022 | 0.03 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.03 | Why? |
| Bacterial Proteins | 1 | 2019 | 1318 | 0.03 | Why? |
| Hydrocortisone | 1 | 2020 | 1790 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Mutagenesis, Site-Directed | 1 | 2010 | 449 | 0.02 | Why? |
| Enzyme Activation | 1 | 2010 | 425 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Alcohol Drinking | 1 | 2020 | 1663 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.02 | Why? |
| Metabolic Networks and Pathways | 1 | 2010 | 285 | 0.02 | Why? |
| Substrate Specificity | 1 | 2010 | 639 | 0.02 | Why? |
| Macrophages | 1 | 2020 | 2784 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
| Epithelial Cells | 1 | 2020 | 3508 | 0.02 | Why? |
| Sleep | 1 | 2020 | 2695 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.02 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.02 | Why? |
| Cloning, Molecular | 1 | 2010 | 1036 | 0.02 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| Peptides | 1 | 2018 | 2513 | 0.02 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.02 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
| Video-Assisted Surgery | 1 | 2005 | 43 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2010 | 3198 | 0.02 | Why? |
| Sequence Alignment | 1 | 2010 | 2109 | 0.02 | Why? |
| Biosensing Techniques | 1 | 2017 | 2116 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Sequence Analysis, DNA | 1 | 2010 | 2830 | 0.01 | Why? |
| Exercise | 1 | 2020 | 6771 | 0.01 | Why? |
| Recombinant Proteins | 1 | 2010 | 3786 | 0.01 | Why? |
| Amino Acid Sequence | 1 | 2010 | 6049 | 0.01 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
| Adolescent | 1 | 2005 | 86841 | 0.00 | Why? |